Foca Gene

Chief Marketing Officer

Foca Gene has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.

On the most recent filing, Foca Gene is listed as Chief Marketing Officer at Getty Images Holdings, Inc. Inside the rolling window, Foca Gene reported no open-market purchases and 3 open-market sales totaling $45K in GETY. The largest disclosed transaction in the window is a sale of 31,576 GETY shares on Mar 25, 2026, worth $25K.

Companies traded

Other insiders at GETY

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$45K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
GETYSale$25KMar 27SEC ↗
GETYSale$7KDec 30SEC ↗
GETYSale$13KSep 26SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Foca Gene made?

Foca Gene has filed 7 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.

Which companies does Foca Gene trade?

Foca Gene has filed SEC Form 4 disclosures for 1 company, including GETY.

When was Foca Gene's most recent SEC Form 4 filing?

Foca Gene's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.

What is Foca Gene's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Foca Gene is listed as Chief Marketing Officer.

What is Foca Gene's total buy and sell value in the current window?

Inside the rolling retention window, Foca Gene bought $0 and sold $45K based on SEC Form 4 filings.

What was Foca Gene's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 31,576 GETY shares on 2026-03-25, worth $25K, per SEC Form 4 filings.